AstraZeneca and Shiyao Group Limited have reached an exclusive licensing agreement to advance the development of a preclinical innovative small molecule lipoprotein (a) (Lp (a)) inhibitor. According ...

On Monday local time, Danish pharmaceutical giant Novo Nordisk announced that it will acquire Cardio Pharmaceuticals for 1.03 billion euros, and the two companies have reached a related acquisition a ...